InvestorsObserver is giving Ampio Pharmaceuticals Inc (AMPE) an Analyst Rating Rank of 72, meaning AMPE is ranked higher by analysts than 72% of stocks. The average price target for AMPE is $2.5 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating AMPE a Strong Buy today. Find out what this means to you and get the rest of the rankings on AMPE!